Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas

被引:17
|
作者
Mawrin, Christian
Kirches, Elmar
Diete, Sabine
Wiedemann, Falk R.
Schneider, Thomas
Firsching, Raimund
Kropf, Siegfried
Bogerts, Bernhard
Vorwerk, Christian K.
Kruger, Sabine
Dietzmann, Knut
机构
[1] Otto Von Guericke Univ, Dept Neuropathol, Inst Neuropathol, D-39120 Magdeburg, Germany
[2] Otto Von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany
[3] Otto Von Guericke Univ, Dept Neurosurg, D-39120 Magdeburg, Germany
[4] Otto Von Guericke Univ, Dept Biometr, D-39120 Magdeburg, Germany
[5] Otto Von Guericke Univ, Dept Psychiat, D-39120 Magdeburg, Germany
[6] Otto Von Guericke Univ, Dept Ophthalmol, D-39120 Magdeburg, Germany
[7] Otto Von Guericke Univ, Dept Pathol, D-39120 Magdeburg, Germany
关键词
glioblastoma multiforme; FGFR4; survival;
D O I
10.1016/j.canlet.2005.08.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The FGFR4 codon 388 polymorphism (Arg(388), Arg/Gly(388) or Gly(388)) was determined in glioblastoma multiforme (GBM), anaplastic astrocytomas (AA), diffuse astrocytomas (DA), and control muscles. Arg(388) was rare in AA, GBM, muscles, and was absent in DA. The Arg/Gly(388) and the Gly(388) frequency was equal among GBM and controls. FGFR4 expression was not related to codon 388 in GBM, and no survival differences between Arg/Gly(388) and Gly(388) tumors were found. U87 cells (Arg/Gly(388)) did not show higher invasion than U138 cells (Gly(388)). This suggests that the FGFR4 codon 388 status does not play a major role in malignant gliomas. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 50 条
  • [31] The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
    Shim, Hyun-Jeong
    Shin, Min-Ho
    Kim, Hee-Nam
    Kim, Jo-Heon
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Chung, Ik-Joo
    Cho, Sang-Hee
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 71 - 79
  • [32] The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet
    Lutz, Stefan Z.
    Hennige, Anita M.
    Peter, Andreas
    Kovarova, Marketa
    Totsikas, Charisis
    Machann, Jurgen
    Kroeber, Stefan M.
    Sperl, Bianca
    Schleicher, Erwin
    Schick, Fritz
    Heni, Martin
    Ullrich, Axel
    Haering, Hans-Ulrich
    Stefan, Norbert
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 2041 - 2053
  • [33] FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan
    Li, Ju-Pi
    Huang, Hsien-Cheng
    Yang, Po-Jen
    Chang, Chien-Yuan
    Chao, Yu-Hua
    Tsao, Thomas Chang-Yao
    Huang, Hsuan
    Hung, Yu-Ching
    Hsieh, Ming-Ju
    Yang, Shun-Fa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (16) : 1 - 11
  • [34] Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension
    Al-Daghri, Nasser M.
    Mohammed, Abdul Khader
    Al-Attas, Omar S.
    Draz, Hossam M.
    Alokail, Majed S.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2017, 21 (07) : 422 - 427
  • [35] The role of FGFR4 polymorphism in the development and progression of bladder cancer
    Yang, YC
    Lu, ML
    Cao, W
    Cai, L
    Cordon-Cardo, C
    Reute, V
    Wallerand, H
    Chopin, DK
    Rao, JY
    Zhang, ZF
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 412 - 412
  • [36] The effect of FGFR4 Gly388Arg polymorphism on treatment outcomes after chemoradiotherapy in esophageal cancer patients.
    Cho, Sanghee
    Shim, Hyung-Jung
    Hwang, Jun-Eul
    Bae, Woo Kyun
    Nam, Taek-Keun
    Shin, Min-Ho
    Jung, Sook-In
    Oh, In-Jae
    Chung, Ik-Joo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Association of the prognostic role of FGFR4 Gly388Arg polymorphism with treatment outcomes after chemoradiotherapy in esophageal cancer
    Cho, Sanghee
    Shin, Min-Ho
    Hwang, Jun-Eul
    Shim, Hyung-Jung
    Kim, Min-Jee
    Chung, Ik-Joo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [38] Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
    Cros, Jerome
    Moati, Emilie
    Raffenne, Jerome
    Hentic, Olivia
    Svrcek, Magali
    de Mestier, Louis
    Sbidian, Emilie
    Guedj, Nathalie
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Panis, Yves
    Ruszniewski, Philippe
    Couvelard, Anne
    Hammel, Pascal
    NEUROENDOCRINOLOGY, 2016, 103 (05) : 495 - 499
  • [39] IDENTIFICATION OF FGFR4 p.G388R VARIANT IN CEREBELLAR HEMANGIOBLASTOMAS
    Snuderl, Matija
    Kannan, Kasthuri
    Gagner, Jean-Pierre
    Mashiach, Elad
    Karajannis, Matthias
    Heguy, Adriana
    Zagzag, David
    NEURO-ONCOLOGY, 2019, 21 : 111 - 111
  • [40] FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
    Xu, Bin
    Tong, Na
    Chen, Shu Q.
    Hua, Li X.
    Wang, Zeng J.
    Zhang, Zheng D.
    Chen, Ming
    BMC CANCER, 2011, 11